NASDAQ_ MRNA

Moderna Inc. (NASDAQ: MRNA) has emerged as a key player in the biotechnology sector, particularly in the wake of the global COVID-19 pandemic. This Massachusetts-based company, founded in 2010, leverages messenger RNA (mRNA) technology to develop vaccines and therapeutics, fundamentally altering the landscape of the pharmaceutical industry. forex